115 related articles for article (PubMed ID: 7771156)
1. [The outer membranes of Vibrio cholerae as a potential component in a chemical vaccine].
Markov EIu; Urbanovich LIa; Golubinskiĭ EP; Chernov AB; Karetnikova ES; Ivanova TA; Pakulev NA
Zh Mikrobiol Epidemiol Immunobiol; 1995; Suppl 2():86-9. PubMed ID: 7771156
[TBL] [Abstract][Full Text] [Related]
2. [The characteristics of the protectiveness of a preparation of Vibrio cholerae outer membrane based on the data from a study using the ligated intestinal loop].
Urbanovich LIa; Sappo SG; Kolesnik RS; Golubinskiĭ EP; Markov EIu; Ganin VS; Ivanova TA
Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):43-6. PubMed ID: 9245140
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective efficacy of Vibrio cholerae outer membrane vesicles in rabbit model.
Roy N; Barman S; Ghosh A; Pal A; Chakraborty K; Das SS; Saha DR; Yamasaki S; Koley H
FEMS Immunol Med Microbiol; 2010 Oct; 60(1):18-27. PubMed ID: 20528929
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity.
Sinha R; Howlader DR; Ta A; Mitra S; Das S; Koley H
Vaccine; 2017 Jun; 35(28):3534-3547. PubMed ID: 28545924
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.
Eko FO; Schukovskaya T; Lotzmanova EY; Firstova VV; Emalyanova NV; Klueva SN; Kravtzov AL; Livanova LF; Kutyrev VV; Igietseme JU; Lubitz W
Vaccine; 2003 Sep; 21(25-26):3663-74. PubMed ID: 12922096
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of different subcellular fractions of Vibrio cholerae O139 in protection to challenge in experimental cholera.
Bondre VP; Sinha VB; Srivastava BS
FEMS Immunol Med Microbiol; 1997 Dec; 19(4):323-9. PubMed ID: 9537758
[TBL] [Abstract][Full Text] [Related]
7. [Systemic immunity of experimental animals immunized with cholera vaccines].
Genova IuG; Bogatinov VT; Manakhilov RB; Kostova EF
Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):41-4. PubMed ID: 3434048
[TBL] [Abstract][Full Text] [Related]
8. [An oral chemical vaccine from the hypertoxigenic strains of the causative agent of cholera KM-76 Inaba and KM-68 Ogawa].
Dzhaparidze MN; Naumov AV; Nikitina GP; Meleshchenko MV; Dobrova GV; Zavorotnykh VI; Gracheva VP; Zakharova TL
Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):31-3. PubMed ID: 1882603
[TBL] [Abstract][Full Text] [Related]
9. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
Liao J; Gibson JA; Pickering BS; Watnick PI
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
Cryz SJ; Fürer E; Germanier R
Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera.
Schild S; Nelson EJ; Bishop AL; Camilli A
Infect Immun; 2009 Jan; 77(1):472-84. PubMed ID: 19001078
[TBL] [Abstract][Full Text] [Related]
12. Investigation into immunological responses against a native recombinant CTB whole-cell Vibrio cholerae vaccine in a rabbit model.
Boustanshenas M; Bakhshi B; Ghorbani M
J Appl Microbiol; 2013 Feb; 114(2):509-15. PubMed ID: 23082752
[TBL] [Abstract][Full Text] [Related]
13. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
[TBL] [Abstract][Full Text] [Related]
14. Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.
Schild S; Nelson EJ; Camilli A
Infect Immun; 2008 Oct; 76(10):4554-63. PubMed ID: 18678672
[TBL] [Abstract][Full Text] [Related]
15. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
[TBL] [Abstract][Full Text] [Related]
16. Protection against infection with Vibrio cholerae by passive transfer of monoclonal antibodies to outer membrane antigens.
Sciortino CV
J Infect Dis; 1989 Aug; 160(2):248-52. PubMed ID: 2760481
[TBL] [Abstract][Full Text] [Related]
17. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
19. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
Kundu J; Mazumder R; Srivastava R; Srivastava BS
FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
[TBL] [Abstract][Full Text] [Related]
20. Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
Talavera A; Año G; Pino Y; Castaño J; Uribarri E; Riverón L; Gil S; Fernández S; Cedré B; Valmaseda T; Pérez JL; Infante JF; García L; Sierra G
Vaccine; 2006 Apr; 24(16):3381-7. PubMed ID: 16460846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
